10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.53
0.29 (2.19%)
At close: Aug 15, 2025, 10:01 AM

10x Genomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
610.78M 618.73M 516.41M 490.49M
Cost of Revenue
196.3M 209.41M 120.39M 74.09M
Gross Profit
414.48M 409.31M 396.02M 416.4M
Operating Income
-194.56M -265.33M -167.94M -52.91M
Interest Income
18.45M 16.91M 6.65M 206K
Pretax Income
-177.7M -248.76M -161.97M -53.72M
Net Income
-182.63M -255.1M -166M -58.22M
Selling & General & Admin
344.34M 343.33M 298.3M 257.56M
Research & Development
264.7M 270.33M 265.67M 211.75M
Other Expenses
n/a 61.29M n/a n/a
Operating Expenses
609.04M 674.95M 563.97M 469.31M
Interest Expense
4K 33K 476K 866K
Selling & Marketing Expenses
3.9M 3.3M 3.7M 4.7M
Cost & Expenses
805.34M 884.36M 684.35M 543.4M
Income Tax Expense
4.93M 6.34M 4.03M 4.51M
Shares Outstanding (Basic)
120.45M 117.17M 113.86M 110.35M
Shares Outstanding (Diluted)
120.45M 117.17M 113.86M 110.35M
EPS (Basic)
-1.52 -2.18 -1.46 -0.53
EPS (Diluted)
-1.52 -2.18 -1.46 -0.53
EBITDA
-133.99M -205.11M -128.49M -24.59M
EBIT
-177.7M -248.73M -161.5M -52.85M
Depreciation & Amortization
43.71M 43.62M 33.01M 28.25M